DIVA Laboratories, Ltd.
TWO: 4153.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Chen Gene
- Employees
- 154
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2012
- Market cap
- NT$1.8B
- Website
- https://www.diva.com.tw
Loading 4153…
Loading profile data…Frequently asked questions about 4153
What does DIVA Laboratories, Ltd. (4153.TWO) do?
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. The company provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays/human machine interface products; medical and indu...
Where does 4153.TWO trade?
DIVA Laboratories, Ltd. (4153.TWO) trades on the Taipei Exchange.
What sector is 4153.TWO in?
DIVA Laboratories, Ltd. (4153.TWO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of DIVA Laboratories, Ltd.?
Chen Gene is the chief executive officer of DIVA Laboratories, Ltd. (4153.TWO).
Where is DIVA Laboratories, Ltd. headquartered?
DIVA Laboratories, Ltd. is headquartered in Taiwan.
Does 4153.TWO pay a dividend?
Yes — DIVA Laboratories, Ltd. (4153.TWO) paid a trailing twelve-month dividend of TWD 2.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4153.TWO go public?
DIVA Laboratories, Ltd. (4153.TWO) completed its initial public offering in 2012.